Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by diamondmine8xon Jul 02, 2010 6:45pm
595 Views
Post# 17240595

Stem Cell Therapeutics results

Stem Cell Therapeutics results Stem Cell Therapeutics results canadian TSX penny stock news trade results


news DD
https://www.TSXpennystock-news.info/?Stemcell_news






Price Change % Change Volume Day High/Low 52 Week High/Low
0.05 -0.005 -9.09% 276,000 0.055/0.05 0.55/0.045
Last Traded:
7/2/10 15:59 EST
Transaction Volume
9,000
Open
0.055
Prev. Close
0.055
Bid
0.05
Ask
0.055
Bid Size
999,000
Ask Size
609,000
Market Cap (Mil)
7.65
Shares Out (mil)
153.01
Signal
StockScore
32Neutral stockscore. Click to learn more.
Sentiment
StockScore
31Bearish stockscore. Click to learn more.
Industry:
HEALTHCARE - DRUGS
Advanced Charts|View History






Bullboard Posts